awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34464827-3ABF8A0A-6C99-46DF-8577-7852B2A31028
Q34464827-3ABF8A0A-6C99-46DF-8577-7852B2A31028
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34464827-3ABF8A0A-6C99-46DF-8577-7852B2A31028
Risk factors for metastatic castration-resistant prostate cancer (CRPC) predict long-term treatment with docetaxel
P2860
Q34464827-3ABF8A0A-6C99-46DF-8577-7852B2A31028
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34464827-3ABF8A0A-6C99-46DF-8577-7852B2A31028
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a288f6d4cb024daa5bad22935f15cff66d7826c2
P2860
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).